Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Progressive Supranuclear Palsy Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Early Stage
1.2.3 Clinical Trial
1.2.4 Late Stage
1.2.5 Others
1.3 Market by Application
1.3.1 Global Progressive Supranuclear Palsy Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Progressive Supranuclear Palsy Market Perspective (2018-2034)
2.2 Progressive Supranuclear Palsy Growth Trends by Region
2.2.1 Global Progressive Supranuclear Palsy Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Progressive Supranuclear Palsy Historic Market Size by Region (2018-2023)
2.2.3 Progressive Supranuclear Palsy Forecasted Market Size by Region (2024-2034)
2.3 Progressive Supranuclear Palsy Market Dynamics
2.3.1 Progressive Supranuclear Palsy Industry Trends
2.3.2 Progressive Supranuclear Palsy Market Drivers
2.3.3 Progressive Supranuclear Palsy Market Challenges
2.3.4 Progressive Supranuclear Palsy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Progressive Supranuclear Palsy Players by Revenue
3.1.1 Global Top Progressive Supranuclear Palsy Players by Revenue (2018-2023)
3.1.2 Global Progressive Supranuclear Palsy Revenue Market Share by Players (2018-2023)
3.2 Global Progressive Supranuclear Palsy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Progressive Supranuclear Palsy Revenue
3.4 Global Progressive Supranuclear Palsy Market Concentration Ratio
3.4.1 Global Progressive Supranuclear Palsy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Progressive Supranuclear Palsy Revenue in 2024
3.5 Progressive Supranuclear Palsy Key Players Head office and Area Served
3.6 Key Players Progressive Supranuclear Palsy Product Solution and Service
3.7 Date of Enter into Progressive Supranuclear Palsy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Progressive Supranuclear Palsy Breakdown Data by Type
4.1 Global Progressive Supranuclear Palsy Historic Market Size by Type (2018-2023)
4.2 Global Progressive Supranuclear Palsy Forecasted Market Size by Type (2024-2034)
5 Progressive Supranuclear Palsy Breakdown Data by Application
5.1 Global Progressive Supranuclear Palsy Historic Market Size by Application (2018-2023)
5.2 Global Progressive Supranuclear Palsy Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Progressive Supranuclear Palsy Market Size (2018-2034)
6.2 North America Progressive Supranuclear Palsy Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Progressive Supranuclear Palsy Market Size by Country (2018-2023)
6.4 North America Progressive Supranuclear Palsy Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Progressive Supranuclear Palsy Market Size (2018-2034)
7.2 Europe Progressive Supranuclear Palsy Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Progressive Supranuclear Palsy Market Size by Country (2018-2023)
7.4 Europe Progressive Supranuclear Palsy Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Progressive Supranuclear Palsy Market Size (2018-2034)
8.2 Asia-Pacific Progressive Supranuclear Palsy Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Progressive Supranuclear Palsy Market Size by Region (2018-2023)
8.4 Asia-Pacific Progressive Supranuclear Palsy Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Progressive Supranuclear Palsy Market Size (2018-2034)
9.2 Latin America Progressive Supranuclear Palsy Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Progressive Supranuclear Palsy Market Size by Country (2018-2023)
9.4 Latin America Progressive Supranuclear Palsy Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Progressive Supranuclear Palsy Market Size (2018-2034)
10.2 Middle East & Africa Progressive Supranuclear Palsy Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Progressive Supranuclear Palsy Market Size by Country (2018-2023)
10.4 Middle East & Africa Progressive Supranuclear Palsy Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Merck & Co., Inc.
11.1.1 Merck & Co., Inc. Company Detail
11.1.2 Merck & Co., Inc. Business Overview
11.1.3 Merck & Co., Inc. Progressive Supranuclear Palsy Introduction
11.1.4 Merck & Co., Inc. Revenue in Progressive Supranuclear Palsy Business (2018-2023)
11.1.5 Merck & Co., Inc. Recent Development
11.2 Aton Pharma, Inc.
11.2.1 Aton Pharma, Inc. Company Detail
11.2.2 Aton Pharma, Inc. Business Overview
11.2.3 Aton Pharma, Inc. Progressive Supranuclear Palsy Introduction
11.2.4 Aton Pharma, Inc. Revenue in Progressive Supranuclear Palsy Business (2018-2023)
11.2.5 Aton Pharma, Inc. Recent Development
11.3 Bristol Myers Squibb (BMS)
11.3.1 Bristol Myers Squibb (BMS) Company Detail
11.3.2 Bristol Myers Squibb (BMS) Business Overview
11.3.3 Bristol Myers Squibb (BMS) Progressive Supranuclear Palsy Introduction
11.3.4 Bristol Myers Squibb (BMS) Revenue in Progressive Supranuclear Palsy Business (2018-2023)
11.3.5 Bristol Myers Squibb (BMS) Recent Development
11.4 GlaxoSmithKline plc
11.4.1 GlaxoSmithKline plc Company Detail
11.4.2 GlaxoSmithKline plc Business Overview
11.4.3 GlaxoSmithKline plc Progressive Supranuclear Palsy Introduction
11.4.4 GlaxoSmithKline plc Revenue in Progressive Supranuclear Palsy Business (2018-2023)
11.4.5 GlaxoSmithKline plc Recent Development
11.5 Novartis AG
11.5.1 Novartis AG Company Detail
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Progressive Supranuclear Palsy Introduction
11.5.4 Novartis AG Revenue in Progressive Supranuclear Palsy Business (2018-2023)
11.5.5 Novartis AG Recent Development
11.6 Teva Pharmaceutical Industries Ltd.
11.6.1 Teva Pharmaceutical Industries Ltd. Company Detail
11.6.2 Teva Pharmaceutical Industries Ltd. Business Overview
11.6.3 Teva Pharmaceutical Industries Ltd. Progressive Supranuclear Palsy Introduction
11.6.4 Teva Pharmaceutical Industries Ltd. Revenue in Progressive Supranuclear Palsy Business (2018-2023)
11.6.5 Teva Pharmaceutical Industries Ltd. Recent Development
11.7 AB Science
11.7.1 AB Science Company Detail
11.7.2 AB Science Business Overview
11.7.3 AB Science Progressive Supranuclear Palsy Introduction
11.7.4 AB Science Revenue in Progressive Supranuclear Palsy Business (2018-2023)
11.7.5 AB Science Recent Development
11.8 AbbVie Inc.
11.8.1 AbbVie Inc. Company Detail
11.8.2 AbbVie Inc. Business Overview
11.8.3 AbbVie Inc. Progressive Supranuclear Palsy Introduction
11.8.4 AbbVie Inc. Revenue in Progressive Supranuclear Palsy Business (2018-2023)
11.8.5 AbbVie Inc. Recent Development
11.9 AlzProtect SAS
11.9.1 AlzProtect SAS Company Detail
11.9.2 AlzProtect SAS Business Overview
11.9.3 AlzProtect SAS Progressive Supranuclear Palsy Introduction
11.9.4 AlzProtect SAS Revenue in Progressive Supranuclear Palsy Business (2018-2023)
11.9.5 AlzProtect SAS Recent Development
11.10 Cortice Biosciences, Inc.
11.10.1 Cortice Biosciences, Inc. Company Detail
11.10.2 Cortice Biosciences, Inc. Business Overview
11.10.3 Cortice Biosciences, Inc. Progressive Supranuclear Palsy Introduction
11.10.4 Cortice Biosciences, Inc. Revenue in Progressive Supranuclear Palsy Business (2018-2023)
11.10.5 Cortice Biosciences, Inc. Recent Development
11.11 Acorda Therapeutics Inc.
11.11.1 Acorda Therapeutics Inc. Company Detail
11.11.2 Acorda Therapeutics Inc. Business Overview
11.11.3 Acorda Therapeutics Inc. Progressive Supranuclear Palsy Introduction
11.11.4 Acorda Therapeutics Inc. Revenue in Progressive Supranuclear Palsy Business (2018-2023)
11.11.5 Acorda Therapeutics Inc. Recent Development
11.12 Biogen Inc.
11.12.1 Biogen Inc. Company Detail
11.12.2 Biogen Inc. Business Overview
11.12.3 Biogen Inc. Progressive Supranuclear Palsy Introduction
11.12.4 Biogen Inc. Revenue in Progressive Supranuclear Palsy Business (2018-2023)
11.12.5 Biogen Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Progressive Supranuclear Palsy Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Early Stage
Table 3. Key Players of Clinical Trial
Table 4. Key Players of Late Stage
Table 5. Key Players of Others
Table 6. Global Progressive Supranuclear Palsy Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Progressive Supranuclear Palsy Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global Progressive Supranuclear Palsy Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Progressive Supranuclear Palsy Market Share by Region (2018-2023)
Table 10. Global Progressive Supranuclear Palsy Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Progressive Supranuclear Palsy Market Share by Region (2024-2034)
Table 12. Progressive Supranuclear Palsy Market Trends
Table 13. Progressive Supranuclear Palsy Market Drivers
Table 14. Progressive Supranuclear Palsy Market Challenges
Table 15. Progressive Supranuclear Palsy Market Restraints
Table 16. Global Progressive Supranuclear Palsy Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Progressive Supranuclear Palsy Market Share by Players (2018-2023)
Table 18. Global Top Progressive Supranuclear Palsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Progressive Supranuclear Palsy as of 2024)
Table 19. Ranking of Global Top Progressive Supranuclear Palsy Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Progressive Supranuclear Palsy Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Progressive Supranuclear Palsy Product Solution and Service
Table 23. Date of Enter into Progressive Supranuclear Palsy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Progressive Supranuclear Palsy Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Progressive Supranuclear Palsy Revenue Market Share by Type (2018-2023)
Table 27. Global Progressive Supranuclear Palsy Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Progressive Supranuclear Palsy Revenue Market Share by Type (2024-2034)
Table 29. Global Progressive Supranuclear Palsy Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Progressive Supranuclear Palsy Revenue Market Share by Application (2018-2023)
Table 31. Global Progressive Supranuclear Palsy Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Progressive Supranuclear Palsy Revenue Market Share by Application (2024-2034)
Table 33. North America Progressive Supranuclear Palsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 34. North America Progressive Supranuclear Palsy Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Progressive Supranuclear Palsy Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe Progressive Supranuclear Palsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. Europe Progressive Supranuclear Palsy Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Progressive Supranuclear Palsy Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific Progressive Supranuclear Palsy Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 40. Asia-Pacific Progressive Supranuclear Palsy Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Progressive Supranuclear Palsy Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America Progressive Supranuclear Palsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. Latin America Progressive Supranuclear Palsy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Progressive Supranuclear Palsy Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Progressive Supranuclear Palsy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 46. Middle East & Africa Progressive Supranuclear Palsy Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Progressive Supranuclear Palsy Market Size by Country (2024-2034) & (US$ Million)
Table 48. Merck & Co., Inc. Company Detail
Table 49. Merck & Co., Inc. Business Overview
Table 50. Merck & Co., Inc. Progressive Supranuclear Palsy Product
Table 51. Merck & Co., Inc. Revenue in Progressive Supranuclear Palsy Business (2018-2023) & (US$ Million)
Table 52. Merck & Co., Inc. Recent Development
Table 53. Aton Pharma, Inc. Company Detail
Table 54. Aton Pharma, Inc. Business Overview
Table 55. Aton Pharma, Inc. Progressive Supranuclear Palsy Product
Table 56. Aton Pharma, Inc. Revenue in Progressive Supranuclear Palsy Business (2018-2023) & (US$ Million)
Table 57. Aton Pharma, Inc. Recent Development
Table 58. Bristol Myers Squibb (BMS) Company Detail
Table 59. Bristol Myers Squibb (BMS) Business Overview
Table 60. Bristol Myers Squibb (BMS) Progressive Supranuclear Palsy Product
Table 61. Bristol Myers Squibb (BMS) Revenue in Progressive Supranuclear Palsy Business (2018-2023) & (US$ Million)
Table 62. Bristol Myers Squibb (BMS) Recent Development
Table 63. GlaxoSmithKline plc Company Detail
Table 64. GlaxoSmithKline plc Business Overview
Table 65. GlaxoSmithKline plc Progressive Supranuclear Palsy Product
Table 66. GlaxoSmithKline plc Revenue in Progressive Supranuclear Palsy Business (2018-2023) & (US$ Million)
Table 67. GlaxoSmithKline plc Recent Development
Table 68. Novartis AG Company Detail
Table 69. Novartis AG Business Overview
Table 70. Novartis AG Progressive Supranuclear Palsy Product
Table 71. Novartis AG Revenue in Progressive Supranuclear Palsy Business (2018-2023) & (US$ Million)
Table 72. Novartis AG Recent Development
Table 73. Teva Pharmaceutical Industries Ltd. Company Detail
Table 74. Teva Pharmaceutical Industries Ltd. Business Overview
Table 75. Teva Pharmaceutical Industries Ltd. Progressive Supranuclear Palsy Product
Table 76. Teva Pharmaceutical Industries Ltd. Revenue in Progressive Supranuclear Palsy Business (2018-2023) & (US$ Million)
Table 77. Teva Pharmaceutical Industries Ltd. Recent Development
Table 78. AB Science Company Detail
Table 79. AB Science Business Overview
Table 80. AB Science Progressive Supranuclear Palsy Product
Table 81. AB Science Revenue in Progressive Supranuclear Palsy Business (2018-2023) & (US$ Million)
Table 82. AB Science Recent Development
Table 83. AbbVie Inc. Company Detail
Table 84. AbbVie Inc. Business Overview
Table 85. AbbVie Inc. Progressive Supranuclear Palsy Product
Table 86. AbbVie Inc. Revenue in Progressive Supranuclear Palsy Business (2018-2023) & (US$ Million)
Table 87. AbbVie Inc. Recent Development
Table 88. AlzProtect SAS Company Detail
Table 89. AlzProtect SAS Business Overview
Table 90. AlzProtect SAS Progressive Supranuclear Palsy Product
Table 91. AlzProtect SAS Revenue in Progressive Supranuclear Palsy Business (2018-2023) & (US$ Million)
Table 92. AlzProtect SAS Recent Development
Table 93. Cortice Biosciences, Inc. Company Detail
Table 94. Cortice Biosciences, Inc. Business Overview
Table 95. Cortice Biosciences, Inc. Progressive Supranuclear Palsy Product
Table 96. Cortice Biosciences, Inc. Revenue in Progressive Supranuclear Palsy Business (2018-2023) & (US$ Million)
Table 97. Cortice Biosciences, Inc. Recent Development
Table 98. Acorda Therapeutics Inc. Company Detail
Table 99. Acorda Therapeutics Inc. Business Overview
Table 100. Acorda Therapeutics Inc. Progressive Supranuclear Palsy Product
Table 101. Acorda Therapeutics Inc. Revenue in Progressive Supranuclear Palsy Business (2018-2023) & (US$ Million)
Table 102. Acorda Therapeutics Inc. Recent Development
Table 103. Biogen Inc. Company Detail
Table 104. Biogen Inc. Business Overview
Table 105. Biogen Inc. Progressive Supranuclear Palsy Product
Table 106. Biogen Inc. Revenue in Progressive Supranuclear Palsy Business (2018-2023) & (US$ Million)
Table 107. Biogen Inc. Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Progressive Supranuclear Palsy Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Progressive Supranuclear Palsy Market Share by Type: 2024 VS 2034
Figure 3. Early Stage Features
Figure 4. Clinical Trial Features
Figure 5. Late Stage Features
Figure 6. Others Features
Figure 7. Global Progressive Supranuclear Palsy Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 8. Global Progressive Supranuclear Palsy Market Share by Application: 2024 VS 2034
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Research Institutes Case Studies
Figure 12. Others Case Studies
Figure 13. Progressive Supranuclear Palsy Report Years Considered
Figure 14. Global Progressive Supranuclear Palsy Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 15. Global Progressive Supranuclear Palsy Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 16. Global Progressive Supranuclear Palsy Market Share by Region: 2024 VS 2034
Figure 17. Global Progressive Supranuclear Palsy Market Share by Players in 2024
Figure 18. Global Top Progressive Supranuclear Palsy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Progressive Supranuclear Palsy as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Progressive Supranuclear Palsy Revenue in 2024
Figure 20. North America Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. North America Progressive Supranuclear Palsy Market Share by Country (2018-2034)
Figure 22. United States Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Canada Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. Europe Progressive Supranuclear Palsy Market Share by Country (2018-2034)
Figure 26. Germany Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. France Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. U.K. Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Italy Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Russia Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Nordic Countries Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Asia-Pacific Progressive Supranuclear Palsy Market Share by Region (2018-2034)
Figure 34. China Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Japan Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. South Korea Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Southeast Asia Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. India Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Australia Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Latin America Progressive Supranuclear Palsy Market Share by Country (2018-2034)
Figure 42. Mexico Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Brazil Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Middle East & Africa Progressive Supranuclear Palsy Market Share by Country (2018-2034)
Figure 46. Turkey Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Saudi Arabia Progressive Supranuclear Palsy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Merck & Co., Inc. Revenue Growth Rate in Progressive Supranuclear Palsy Business (2018-2023)
Figure 49. Aton Pharma, Inc. Revenue Growth Rate in Progressive Supranuclear Palsy Business (2018-2023)
Figure 50. Bristol Myers Squibb (BMS) Revenue Growth Rate in Progressive Supranuclear Palsy Business (2018-2023)
Figure 51. GlaxoSmithKline plc Revenue Growth Rate in Progressive Supranuclear Palsy Business (2018-2023)
Figure 52. Novartis AG Revenue Growth Rate in Progressive Supranuclear Palsy Business (2018-2023)
Figure 53. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Progressive Supranuclear Palsy Business (2018-2023)
Figure 54. AB Science Revenue Growth Rate in Progressive Supranuclear Palsy Business (2018-2023)
Figure 55. AbbVie Inc. Revenue Growth Rate in Progressive Supranuclear Palsy Business (2018-2023)
Figure 56. AlzProtect SAS Revenue Growth Rate in Progressive Supranuclear Palsy Business (2018-2023)
Figure 57. Cortice Biosciences, Inc. Revenue Growth Rate in Progressive Supranuclear Palsy Business (2018-2023)
Figure 58. Acorda Therapeutics Inc. Revenue Growth Rate in Progressive Supranuclear Palsy Business (2018-2023)
Figure 59. Biogen Inc. Revenue Growth Rate in Progressive Supranuclear Palsy Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed